Published in AIDS Behav on October 01, 2010
A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. PLoS One (2010) 1.97
Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model. PLoS One (2010) 1.54
Microbicide clinical trial adherence: insights for introduction. J Int AIDS Soc (2013) 1.47
Effect of computer-assisted interviewing on self-reported sexual behavior data in a microbicide clinical trial. AIDS Behav (2013) 1.32
Using modeling to help understand vaginal microbicide functionality and create better products. Drug Deliv Transl Res (2011) 1.06
Adherence in the CAPRISA 004 tenofovir gel microbicide trial. AIDS Behav (2014) 1.06
Clinical evaluation of microbicide formulations. Antiviral Res (2010) 1.05
Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties. AIDS Res Hum Retroviruses (2013) 1.04
Validation of a dye stain assay for vaginally inserted hydroxyethylcellulose-filled microbicide applicators. Sex Transm Dis (2011) 1.03
Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trials. Sex Transm Dis (2013) 0.98
Disclosure of pharmacokinetic drug results to understand nonadherence. AIDS (2015) 0.96
Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies. Curr Opin HIV AIDS (2015) 0.93
Feasibility, performance, and acceptability of the Wisebag™ for potential monitoring of daily gel applicator use in Durban, South Africa. AIDS Behav (2013) 0.91
Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa. PLoS One (2016) 0.91
An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings. J Int AIDS Soc (2014) 0.90
A temperature-monitoring vaginal ring for measuring adherence. PLoS One (2015) 0.86
Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings. J Int AIDS Soc (2016) 0.83
Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reporting. AIDS Behav (2013) 0.83
Update on microbicide research and development - seeking new HIV prevention tools for women. Eur J Med Res (2011) 0.81
Use of a novel technology to track adherence to product use in a microbicide trial of short duration (MTN-007). AIDS Behav (2013) 0.81
Monitoring microbicide gel use with real-time notification of the container's opening events: results of the CAPRISA Wisebag study. AIDS Behav (2014) 0.79
High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women. PLoS One (2017) 0.75
Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior. Psychol Bull (1990) 11.25
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet (2002) 11.02
A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med (2001) 9.98
Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav (2006) 8.11
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 7.93
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med (2008) 6.00
Biomarker-adaptive threshold design: a procedure for evaluating treatment with possible biomarker-defined subset effect. J Natl Cancer Inst (2007) 2.68
Condom use measurement in 56 studies of sexual risk behavior: review and recommendations. Arch Sex Behav (2006) 2.21
Enhancing adherence in clinical research. Contemp Clin Trials (2005) 1.32
Using objective markers to assess participant behavior in HIV prevention trials of vaginal microbicides. J Acquir Immune Defic Syndr (2008) 1.26
Comparing compliance patterns between randomized treatments. Control Clin Trials (1997) 1.25
Biomarkers of cervicovaginal inflammation for the assessment of microbicide safety. Sex Transm Dis (2009) 1.25
Task force #4--adherence issues and behavior changes: achieving a long-term solution. 33rd Bethesda Conference. J Am Coll Cardiol (2002) 1.16
Biomarkers of semen exposure. Sex Transm Dis (2009) 1.12
Patterns and predictors of adherence to diaphragm use in a phase III trial in sub-Saharan Africa: a trajectory analysis. J Acquir Immune Defic Syndr (2009) 1.05
Challenges and innovations in enhancing adherence. Control Clin Trials (2004) 0.96
Understanding basic mechanisms and optimizing assays to evaluate the efficacy of vaginal microbicides. Sex Transm Dis (2009) 0.90
Biomarker discovery: validation and decision-making in product development. Sex Transm Dis (2009) 0.82
Structural accelerated failure time models for the effects of observed exposures on repeated events in a clinical trial. Stat Med (2005) 0.82
Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med (2015) 9.20
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med (2008) 6.00
Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials (2007) 4.93
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV (2015) 4.33
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS (2006) 4.23
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet (2010) 3.90
Early age of first sex: a risk factor for HIV infection among women in Zimbabwe. AIDS (2004) 3.30
Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol (2009) 2.57
Microbicide acceptability research: current approaches and future directions. Soc Sci Med (2005) 2.54
Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials (2009) 2.14
Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research. PLoS One (2011) 2.12
Predictors of risky sex of young men after release from prison. Int J STD AIDS (2003) 2.11
Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria. PLoS One (2008) 2.09
Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials. AIDS Behav (2013) 2.03
Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med (2011) 1.89
Monitoring and assessment of wetlands using Earth Observation: the GlobWetland project. J Environ Manage (2008) 1.74
Factors affecting antenatal care attendance: results from qualitative studies in Ghana, Kenya and Malawi. PLoS One (2013) 1.72
'He is now like a brother, I can even give him some blood'--relational ethics and material exchanges in a malaria vaccine 'trial community' in The Gambia. Soc Sci Med (2008) 1.63
Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction (2009) 1.61
HIV, STD, and hepatitis risk to primary female partners of men being released from prison. Women Health (2005) 1.58
Acceptability in microbicide and PrEP trials: current status and a reconceptualization. Curr Opin HIV AIDS (2012) 1.55
Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One (2010) 1.55
Re-framing microbicide acceptability: findings from the MDP301 trial. Cult Health Sex (2010) 1.51
Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women. AIDS (2006) 1.51
Women who sell sex in a Ugandan trading town: life histories, survival strategies and risk. Soc Sci Med (2002) 1.50
Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial. Clin Vaccine Immunol (2011) 1.47
'To help them is to educate them': power and pedagogy in the prevention and treatment of malaria in Tanzania. Trop Med Int Health (2006) 1.40
FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis. J Acquir Immune Defic Syndr (2014) 1.36
Comparison of three assays for the quantification of Candida biomass in suspension and CDC reactor grown biofilms. J Microbiol Methods (2005) 1.35
Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial. J Acquir Immune Defic Syndr (2015) 1.32
Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings. Malar J (2009) 1.26
Multilevel and kin selection in a connected world. Nature (2010) 1.26
Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS (2013) 1.25
Microbicide preference among young women in California. J Womens Health (Larchmt) (2006) 1.23
Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050). AIDS Care (2007) 1.20
What drives community adherence to indoor residual spraying (IRS) against malaria in Manhiça district, rural Mozambique: a qualitative study. Malar J (2011) 1.18
Behavioral and psychosocial program needs of young adult cancer survivors. Qual Health Res (2010) 1.18
Modelling the association between adherence and viral load in HIV-infected patients. Stat Med (2005) 1.16
Intervention format and delivery preferences among young adult cancer survivors. Int J Behav Med (2013) 1.16
Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use. Cult Health Sex (2010) 1.15
Gender relations in the context of HIV/AIDS in rural South Africa. AIDS Care (2007) 1.15
Consistent condom use in married Zimbabwean women after a condom intervention. Sex Transm Dis (2008) 1.13
Group-based citizenship in the acceptance of indoor residual spraying (IRS) for malaria control in Mozambique. Soc Sci Med (2010) 1.12
Culture and end of life care: a scoping exercise in seven European countries. PLoS One (2012) 1.11
The importance of male partner involvement for women's acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe. AIDS Behav (2011) 1.10
Mobility, sexual networks and exchange among bodabodamen in southwest Uganda. Cult Health Sex (2004) 1.10
Barrier method preferences and perceptions among Zimbabwean women and their partners. AIDS Behav (2005) 1.10
Development of behaviour change communication strategy for a vaccination-linked malaria control tool in southern Tanzania. Malar J (2008) 1.09
Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa. AIDS Behav (2009) 1.08
A Text Message Delivered Smoking Cessation Intervention: The Initial Trial of TXT-2-Quit: Randomized Controlled Trial. JMIR Mhealth Uhealth (2013) 1.08
Electronic monitoring of variation in drug intakes can reduce bias and improve precision in pharmacokinetic/pharmacodynamic population studies. Stat Med (2004) 1.08
Socio-cultural aspects of Chagas disease: a systematic review of qualitative research. PLoS Negl Trop Dis (2013) 1.07
Perceptions of anal sex in rural South Africa. Cult Health Sex (2008) 1.07
Living situation affects adherence to combination antiretroviral therapy in HIV-infected adolescents in Rwanda: a qualitative study. PLoS One (2013) 1.06
The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLoS One (2008) 1.06
How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania. BMC Med Ethics (2010) 1.05
Critically engaging: integrating the social and the biomedical in international microbicides research. J Int AIDS Soc (2011) 1.05
The Ghent Marfan Trial--a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers. Int J Cardiol (2011) 1.04
Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sex Transm Dis (2008) 1.03
Analyzing Direct Effects in Randomized Trials with Secondary Interventions: An Application to HIV Prevention Trials. J R Stat Soc Ser A Stat Soc (2009) 1.03
A qualitative study of substance use and sexual behavior among 18- to 29-year-old men while incarcerated in the United States. Health Educ Behav (2004) 1.03
Impact of variance components on reliability of absolute quantification using digital PCR. BMC Bioinformatics (2014) 1.01
HIV-positive smokers considering quitting: differences by race/ethnicity. Am J Health Behav (2007) 1.01
A critical review of advance directives in Germany: attitudes, use and healthcare professionals' compliance. Patient Educ Couns (2011) 1.01
The importance of discreet use of the diaphragm to Zimbabwean women and their partners. AIDS Behav (2006) 1.00
Reasons for non-adherence to vaccination at mother and child care clinics (MCCs) in Lambaréné, Gabon. Vaccine (2009) 1.00
Sexually transmitted disease management in Uganda's private-for-profit formal and informal sector and compliance with treatment. Sex Transm Dis (2004) 1.00
Prevention and management of malaria during pregnancy: findings from a comparative qualitative study in Ghana, Kenya and Malawi. Malar J (2013) 0.99
End of life care in sub-Saharan Africa: a systematic review of the qualitative literature. BMC Palliat Care (2011) 0.98
Degrees of disclosure: a study of women's covert use of the diaphragm in an HIV prevention trial in sub-Saharan Africa. Soc Sci Med (2009) 0.98
African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial. Sex Transm Dis (2011) 0.97
Introducing diaphragms into the mix: what happens to male condom use patterns? AIDS Behav (2005) 0.97
"Male involvement" in women and children's HIV prevention: challenges in definition and interpretation. J Acquir Immune Defic Syndr (2011) 0.97
Inherent illnesses and attacks: an ethnographic study of interpretations of childhood Acute Respiratory Infections (ARIs) in Manhiça, southern Mozambique. BMC Public Health (2011) 0.96
Comparison of sexual behavior data collected using a coital diary and a clinic-based interview during a microbicide pilot study in Mwanza, Tanzania. Sex Transm Dis (2010) 0.96
Local illness concepts and their relevance for the prevention and control of malaria during pregnancy in Ghana, Kenya and Malawi: findings from a comparative qualitative study. Malar J (2013) 0.96
User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa. AIDS Care (2011) 0.95
Duet for menstrual protection: a feasibility study in Zimbabwe. Contraception (2009) 0.95
Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding". AIDS Behav (2015) 0.95
A structural mean model to allow for noncompliance in a randomized trial comparing 2 active treatments. Biostatistics (2010) 0.95
Appraisal of literature reviews on end-of-life care for minority ethnic groups in the UK and a critical comparison with policy recommendations from the UK end-of-life care strategy. BMC Health Serv Res (2011) 0.95
Sharing the trousers: gender roles and relationships in an HIV-prevention trial in Zimbabwe. Cult Health Sex (2012) 0.94
An exploration of the relationship between youth assets and engagement in risky sexual behaviors. J Adolesc Health (2004) 0.94
End-of-life care across Southern Europe: a critical review of cultural similarities and differences between Italy, Spain and Portugal. Crit Rev Oncol Hematol (2011) 0.94
Feasibility of a breath test for monitoring adherence to vaginal administration of antiretroviral microbicide gels. J Clin Pharmacol (2013) 0.93
Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention. Contraception (2011) 0.92
Community response to intermittent preventive treatment of malaria in infants (IPTi) in Papua New Guinea. Malar J (2010) 0.92
The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana. Malar J (2014) 0.92
An acceptability and safety study of the Duet cervical barrier and gel delivery system in Zimbabwe. J Int AIDS Soc (2010) 0.92
Systematic review of the primary research on minority ethnic groups and end-of-life care from the United Kingdom. J Pain Symptom Manage (2011) 0.91
A comparison of four condom-use measures in predicting pregnancy, cervical STI and HIV incidence among Zimbabwean women. Sex Transm Infect (2009) 0.90
"You still need to give her a token of appreciation": the meaning of the exchange of money in the sexual relationships of out-of-school adolescents in rural southwest Uganda. J Sex Res (2010) 0.89
Delaying sexual debut amongst out-of-school youth in rural southwest Uganda. Cult Health Sex (2010) 0.89
"Come back when you're dying:" the commodification of AIDS among California's urban poor. Soc Sci Med (2002) 0.89
Female condom uptake and acceptability in Zimbabwe. AIDS Educ Prev (2008) 0.88
Designing a sequentially randomized study with adherence enhancing interventions for diabetes patients. Stat Med (2010) 0.87
Influences on visit retention in clinical trials: insights from qualitative research during the VOICE trial in Johannesburg, South Africa. BMC Womens Health (2014) 0.87
Decreased condom breakage and slippage rates after counseling men at a sexually transmitted infection clinic in Jamaica. Contraception (2007) 0.86
Intimate partner violence and condom and diaphragm nonadherence among women in an HIV prevention trial in southern Africa. J Acquir Immune Defic Syndr (2013) 0.86